Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Like Growth Factor II | 1 | 2019 | 52 | 0.680 |
Why?
|
| Receptors, Serotonin | 2 | 2017 | 74 | 0.610 |
Why?
|
| Pulmonary Fibrosis | 1 | 2019 | 157 | 0.610 |
Why?
|
| Fibroblasts | 2 | 2019 | 902 | 0.510 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2014 | 34 | 0.470 |
Why?
|
| Mitochondria | 2 | 2017 | 643 | 0.440 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 232 | 0.380 |
Why?
|
| Nomograms | 1 | 2021 | 19 | 0.200 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2018 | 76 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2673 | 0.170 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2019 | 42 | 0.170 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2019 | 59 | 0.170 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 71 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 18 | 0.160 |
Why?
|
| Fluorobenzenes | 2 | 2017 | 10 | 0.160 |
Why?
|
| Phenotype | 1 | 2021 | 947 | 0.160 |
Why?
|
| Carbazoles | 2 | 2017 | 46 | 0.150 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 223 | 0.150 |
Why?
|
| Organelle Biogenesis | 1 | 2017 | 34 | 0.150 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2017 | 81 | 0.150 |
Why?
|
| Rabbits | 2 | 2017 | 509 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 384 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 499 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 493 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2018 | 448 | 0.120 |
Why?
|
| Calcium Channels | 1 | 2015 | 59 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 2791 | 0.120 |
Why?
|
| Electron Transport Complex IV | 1 | 2014 | 33 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 1 | 2014 | 54 | 0.120 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 51 | 0.120 |
Why?
|
| Lung | 1 | 2019 | 849 | 0.120 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 84 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2015 | 201 | 0.110 |
Why?
|
| Indoles | 1 | 2014 | 146 | 0.110 |
Why?
|
| Benzamides | 1 | 2014 | 156 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 807 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 320 | 0.100 |
Why?
|
| Calcium | 1 | 2015 | 929 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2019 | 2689 | 0.090 |
Why?
|
| Neoplasms | 1 | 2021 | 1667 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2014 | 753 | 0.090 |
Why?
|
| Kidney | 1 | 2014 | 945 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1085 | 0.080 |
Why?
|
| Tissue Extracts | 1 | 2008 | 10 | 0.080 |
Why?
|
| Culture Media | 1 | 2008 | 155 | 0.080 |
Why?
|
| Animals | 5 | 2019 | 20881 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2008 | 258 | 0.070 |
Why?
|
| Mice | 2 | 2019 | 8474 | 0.070 |
Why?
|
| Hypertension | 1 | 2015 | 1535 | 0.060 |
Why?
|
| Humans | 7 | 2021 | 68618 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3259 | 0.050 |
Why?
|
| Female | 4 | 2021 | 38074 | 0.050 |
Why?
|
| Male | 4 | 2021 | 37321 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 306 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 1056 | 0.040 |
Why?
|
| NADPH Oxidases | 1 | 2019 | 80 | 0.040 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 66 | 0.040 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2017 | 3 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 247 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 2017 | 53 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2018 | 82 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 434 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 742 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 216 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 2093 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 792 | 0.030 |
Why?
|
| Scleroderma, Systemic | 1 | 2019 | 446 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 706 | 0.030 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2015 | 63 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 718 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1692 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1200 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2015 | 235 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2015 | 220 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 529 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 326 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2015 | 209 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 525 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 791 | 0.030 |
Why?
|
| Sphingosine | 1 | 2015 | 315 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2358 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 21147 | 0.020 |
Why?
|
| Veterans | 1 | 2018 | 904 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2015 | 1330 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5717 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 3705 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 2083 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2015 | 1451 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2008 | 43 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5731 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 475 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 852 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 901 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1745 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1174 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 21403 | 0.010 |
Why?
|